European Network for Cancer Immunotherapy ENCI
@enci-network.bsky.social
ENCI is a collaborative networking platform of the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), the Italian Network for Tumor Biotherapy (NIBIT) and the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA).
Reposted by European Network for Cancer Immunotherapy ENCI
Your front-row seat to the latest in cancer immunotherapy: www.cancerimmunotherapyconference.org Sept 10-12 in Utrecht @cancerresearchinst.bsky.social @enci-network.bsky.social
April 16, 2025 at 11:42 AM
Your front-row seat to the latest in cancer immunotherapy: www.cancerimmunotherapyconference.org Sept 10-12 in Utrecht @cancerresearchinst.bsky.social @enci-network.bsky.social
Reposted by European Network for Cancer Immunotherapy ENCI
Glioblastomas are notoriously resistant—can T-cell therapies change the game?
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
February 18, 2025 at 9:13 AM
Glioblastomas are notoriously resistant—can T-cell therapies change the game?
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
Reposted by European Network for Cancer Immunotherapy ENCI
At #CIMT2025 Ronald Germain @niaidnews.bsky.social will present the cutting-edge world of optical imaging, where advanced 2D and 3D microscopy technology is unveiling how immune cells interact with cancer in unprecedented spatial and molecular detail. www.meeting.cimt.eu #cancerimmunotherapy
January 15, 2025 at 9:02 AM
At #CIMT2025 Ronald Germain @niaidnews.bsky.social will present the cutting-edge world of optical imaging, where advanced 2D and 3D microscopy technology is unveiling how immune cells interact with cancer in unprecedented spatial and molecular detail. www.meeting.cimt.eu #cancerimmunotherapy
Reposted by European Network for Cancer Immunotherapy ENCI
At #CIMT2025 @dgfeller.bsky.social @ludwigcancer.bsky.social will share groundbreaking insights into predicting T-cell receptor (TCR) recognition in cancer by combining traditional T-cell assays with phage display technology and machine learning approaches. Register at www.meeting.cimt.eu
January 21, 2025 at 2:27 PM
At #CIMT2025 @dgfeller.bsky.social @ludwigcancer.bsky.social will share groundbreaking insights into predicting T-cell receptor (TCR) recognition in cancer by combining traditional T-cell assays with phage display technology and machine learning approaches. Register at www.meeting.cimt.eu
Reposted by European Network for Cancer Immunotherapy ENCI
Lei (Stanley) Qi, Stanford University, will present #CRISPR technology and synthetic biology at #CIMT2025 He invented the groundbreaking nuclease-dead dCas and developed precision #CRISPR tools like CRISPR interference, CRISPR activation (CRISPRa), and live cell DNA imaging. www.meeting.cimt.eu
January 13, 2025 at 11:49 AM
Lei (Stanley) Qi, Stanford University, will present #CRISPR technology and synthetic biology at #CIMT2025 He invented the groundbreaking nuclease-dead dCas and developed precision #CRISPR tools like CRISPR interference, CRISPR activation (CRISPRa), and live cell DNA imaging. www.meeting.cimt.eu